Zur Rose Group hands over successful Swiss business to Migros to focus on growth in Germany

Zur Rose Group AG / Key word(s): Disposal Zur Rose Group hands over successful Swiss business to Migros to focus on growth in Germany 03-Feb-2023 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement.   Frauenfeld, 3 February 2023 Press release Ad hoc announcement pursuant to Art. 53 LR   Zur Rose Group hands over successful Swiss business to Migros to focus on growth in Germany

• Zur Rose Group sells its Swiss business to the Migros subsidiary Medbase and focuses on developing its B2C core business (with its focal point) in Germany
• With Migros as a leading healthcare provider, maximum development potential unfolds for Zur Rose Switzerland
• Proceeds of approximately CHF 360 million will flow to Zur Rose Group
• Transaction secures strategy and significantly strengthens capital structure to be best positioned to benefit from e-prescriptions in Germany and digitalisation in the healthcare sector

The Zur Rose Group will focus on its B2C core business going forward – with patients and customers at its centre – it thereby builds on the expertise developed in Switzerland. With this concentration of its business activities, the Group will strengthen its position in the 50 billion Euro pharmacy market in Germany and in additional European countries. This applies in particular to the prescription business, which presents an enormous potential with the rollout of electronic prescriptions in Germany. The Group will continue to expand its digital health ecosystem through services for chronic patients and customers and through strategic collaborations with health partners. The focus lies on profitable growth.